Intuitive Surgical
Sunnyvale, California, United States · Biotechnology, Health Care, Medical
Intuitive Surgical, Inc. is a global technology leader in minimally invasive care and the pioneer of robotic surgery. Their technologies include the da Vinci surgical system and the Ion endoluminal system. Intuitive envisions a future of care that is less invasive and profoundly better, where disease is identified early and treated quickly, so that patients can get back to what matters most.
Key facts
- Headquarters
- Sunnyvale, California, United States
- Employees
- 17,021
- Industries
- Biotechnology, Health Care, Medical
- Status
- Public (ISRG)
- Website
- www.intuitive.com
- Company page
Recent activity at Intuitive Surgical
- : Intuitive Surgical Appoints New Independent Director Aaron Martin
- : SEC 8-K (5.02): On October 29, 2026, the Board of Directors of Intuitive Surgical, Inc. approved an increase in the Board's size from ten to eleven members and appointed Aaron Martin as a new independent director, effective January 1, 2027. Mr. Martin will not serve on any committees and will receive an annual cash retainer of $70,000, plus an initial grant of restricted stock units valued at $93,333, which will be prorated. The RSUs will fully vest either on the first anniversary of the grant date or at the next annual stockholders' meeting, contingent on his continued service. The appointment reinforces the Board's commitment to governance, and his independence is affirmed under Nasdaq and SEC regulations.
- : SEC 8-K (5.02):
- : SEC 8-K (5.02): On April 30, 2026, at Intuitive Surgical, Inc.'s annual meeting, stockholders approved an amendment to the Amended and Restated 2010 Incentive Award Plan, which included increasing the number of shares reserved for issuance from 120,350,000 to 125,350,000 and extending the plan's term to January 29, 2036. This plan now specifies the treatment of awards in connection with a change in control, impacting how future awards will be managed during significant corporate changes. This amendment may enhance the company's ability to retain and incentivize key personnel through stock-based compensation arrangements. The stockholders also voted on the election of ten board members and other proposals related to executive compensation and auditor appointment during this meeting.
- : SEC 8-K (2.02): On April 21, 2026, Intuitive Surgical, Inc. announced its financial results for the quarter ended March 31, 2026. The press release details the company's operational performance and financial condition, providing insights into revenue growth, profit margins, and other key financial metrics. This announcement is crucial for shareholders and potential investors as it outlines the company's performance during a significant fiscal period. The event directly impacts the valuation and market perception of Intuitive Surgical, as it reflects on their business trajectory and market competitiveness.
- : Intuitive Surgical completes acquisition of da Vinci business
- : SEC 8-K (8.01): On March 1, 2026, Intuitive Surgical, Inc. completed its acquisition of the da Vinci and Ion distribution business from ab medica, Abex, Excelencia Robótica, and their affiliates. This strategic acquisition enhances Intuitive Surgical's portfolio in surgical robotics and expands its market presence. The announcement was made via a press release on March 2, 2026, which is included as Exhibit 99.1 in the filing. The financial details of the transaction were not specified in the announcement, but this acquisition is expected to provide significant growth opportunities for the Company.
- : SEC 8-K (2.02): On January 22, 2026, Intuitive Surgical, Inc. announced its financial results for the quarter ended December 31, 2025. The press release details the company's performance metrics, including total revenue, profit margins, and comparisons to prior periods, which are critical for investors and stakeholders. This announcement follows standard reporting requirements and provides insight into the company's operational and financial health, impacting investor sentiment and stock value. The effective date of the reported financial results is December 31, 2025, which is relevant for assessing the company's recent performance.
- : SEC 8-K (2.02): On January 14, 2026, Intuitive Surgical, Inc. announced certain unaudited preliminary fourth quarter and full year 2025 financial results through a press release. This filing provides key financial metrics including revenue and procedural details for the reported periods. The information is not filed for purposes of the Securities Exchange Act but is important for investors to assess the company's financial performance. This announcement reflects the company's ongoing business performance and strategic positioning in the market.
- : SEC 8-K (5.02):
Leadership
- Aaron Martin, Independent Director
- Dave Rosa, Chief Executive Officer
- Jamie Samath, Vice President
- Gary Loeb, Vice President
- Henry Charlton, Vice President
Verified email and direct lines for Intuitive Surgical’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Intuitive Surgical files 4 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Intuitive Surgical in the news
- Intuitive announces enhancements to da Vinci 5 ecosystem, including instruments, security - MassDevice (May 21, 2026)
- Cost of Robotic Surgery Remains Complex Equation - The American College of Surgeons (Feb 04, 2026)
- Intuitive expands in Europe with purchase of distributor operations - MedTech Dive (Mar 02, 2026)
- Intuitive Surgical Expands Platforms Despite Market Headwind - Medical Device Network (Jan 15, 2026)
- Intuitive Shares Vision for an AI-Enabled Future of Healthcare - GlobeNewswire (Jul 23, 2026)
- Intuitive Surgical slides as investors continue to digest cautious outlook | ISRG Stock News - Quiver Quantitative (Aug 20, 2026)
- Intuitive Surgical hit by phishing incident - MedTech Dive (Mar 13, 2026)
- Intuitive Surgical’s Dave Rosa on robotic surgery’s next era - Modern Healthcare (Aug 07, 2026)
Companies similar to Intuitive Surgical
- Zimmer · Biotechnology, Health Care, Medical, Medical Device
- Solventum · Biotechnology, Health Care, Medical, Medical Device
- Teleflex · Biotechnology, Health Care, Medical, Medical Device
- Edwards Lifesciences · Biotechnology, Health Care, Medical, Medical Device
- Mindray · Biotechnology, Health Care, Medical, Medical Device
About Intuitive Surgical: questions and answers
What does Intuitive Surgical do?
Intuitive Surgical, Inc. is a global technology leader in minimally invasive care and the pioneer of robotic surgery. Their technologies include the da Vinci surgical system and the Ion endoluminal system. Intuitive envisions a future of care that is less invasive and profoundly better, where disease is identified early and treated quickly, so that patients can get back to what matters most.
Where is Intuitive Surgical headquartered?
Intuitive Surgical is headquartered in Sunnyvale, California, United States.
How many employees does Intuitive Surgical have?
Intuitive Surgical has about 17,021 employees.
Who leads Intuitive Surgical?
Dave Rosa is a Chief Executive Officer at Intuitive Surgical.
What is the latest news on Intuitive Surgical?
On Nov 02, 2026, Intuitive Surgical Appoints New Independent Director Aaron Martin
Is Intuitive Surgical a public company?
Yes. Intuitive Surgical is publicly traded under the ticker ISRG.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy